Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery1
暂无分享,去创建一个
P. Tam | J. Lamb | Liwei Lu | Zhengwei Yuan | L. Tian
[1] M. Sayegh,et al. New Insights Into the Interactions Between T-Cell Costimulatory Blockade and Conventional Immunosuppressive Drugs , 2002, Annals of surgery.
[2] J. Bijlsma,et al. Antigen‐specific T cell suppression by human CD4+CD25+ regulatory T cells , 2002, European journal of immunology.
[3] M. Karim,et al. CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses1 , 2002, The Journal of Immunology.
[4] J. Camardo,et al. Rapamycin: clinical results and future opportunities. , 2001, Transplantation.
[5] Sayuri Yamazaki,et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.
[6] J. D. de Fijter,et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. , 2001, Blood.
[7] H. Waldmann,et al. Regulating the immune response to transplants. a role for CD4+ regulatory cells? , 2001, Immunity.
[8] F. Powrie,et al. IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1 , 2001, The Journal of Immunology.
[9] M. Metcalfe,et al. Rapamycin in transplantation: a review of the evidence. , 2001, Kidney international.
[10] M. Hidalgo,et al. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy , 2000, Oncogene.
[11] R. Morris,et al. Graft-versus-host disease prevention by rapamycin: cellular mechanisms. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[12] L. Turka,et al. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. , 2000, Transplantation.
[13] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.
[14] Liwei Lu,et al. Apoptosis and its modulation during B lymphopoiesis in mouse bone marrow , 2000, Immunological reviews.
[15] S. Sakaguchi. Regulatory T cells , 2000, Cell.
[16] B. Haynes,et al. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. , 2000, Annual review of immunology.
[17] T. Strom,et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.
[18] R. Poston,et al. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. , 1999, Circulation.
[19] R. Schwartz,et al. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. , 1999, Journal of immunology.
[20] R. Abraham,et al. Immunopharmacology of rapamycin. , 1996, Annual review of immunology.
[21] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[22] M. Kubo,et al. T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection , 1995, The Journal of experimental medicine.
[23] R. Abraham,et al. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells. , 1995, Progress in cell cycle research.
[24] Hongyu Luo,et al. The effect of rapamycin on T cell development in mice , 1994, European journal of immunology.
[25] D. Snover,et al. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. , 1993, Journal of immunology.
[26] B. Blazar,et al. Rapamycin Prolongs Survival of Murine Recipients of Fully Allogeneic Donor Grafts When Administered during the Graft‐versus‐Host Disease Process a , 1993, Annals of the New York Academy of Sciences.
[27] J. Sprent,et al. Abnormal differentiation of thymocytes in mice treated with cyclosporin A , 1988, Nature.
[28] R. Schwartz,et al. Effects of cyclosporine A on T cell development and clonal deletion. , 1988, Science.